Ardent Health Partners, LLC
ARDT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,576,746 | $1,645,280 | $1,497,234 | $1,606,289 |
| % Growth | -4.2% | 9.9% | -6.8% | – |
| Cost of Goods Sold | $676,962 | $270,639 | $258,855 | $653,966 |
| Gross Profit | $899,784 | $1,374,641 | $1,238,379 | $952,323 |
| % Margin | 57.1% | 83.6% | 82.7% | 59.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $305,083 | $1,034,353 | $1,004,320 | $286,299 |
| SG&A Expenses | $645,456 | $1,034,353 | $1,004,320 | $615,529 |
| Sales & Mktg Exp. | $340,373 | $0 | $0 | $329,230 |
| Other Operating Expenses | $0 | $203,007 | $166,968 | $0 |
| Operating Expenses | $645,456 | $1,237,360 | $1,171,288 | $615,529 |
| Operating Income | $254,328 | $137,281 | $67,091 | $336,794 |
| % Margin | 16.1% | 8.3% | 4.5% | 21% |
| Other Income/Exp. Net | -$256,531 | -$15,289 | $7,107 | -$169,548 |
| Pre-Tax Income | -$2,203 | $121,992 | $74,198 | $167,246 |
| Tax Expense | -$3,410 | $26,291 | $15,233 | $26,355 |
| Net Income | -$23,478 | $72,950 | $41,383 | $114,204 |
| % Margin | -1.5% | 4.4% | 2.8% | 7.1% |
| EPS | -0.17 | 0.52 | 0.3 | 0.8 |
| % Growth | -132.7% | 73.3% | -62.5% | – |
| EPS Diluted | -0.17 | 0.52 | 0.29 | 0.86 |
| Weighted Avg Shares Out | 140,569 | 140,219 | 140,062 | 142,748 |
| Weighted Avg Shares Out Dil | 141,242 | 141,112 | 140,704 | 132,745 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $13,914 | $14,729 | $14,176 | $13,528 |
| Depreciation & Amortization | $39,156 | $39,309 | $36,201 | $37,854 |
| EBITDA | $55,614 | $176,030 | $124,575 | $195,426 |
| % Margin | 3.5% | 10.7% | 8.3% | 12.2% |